SpaceX Starship prototype rocket explodes after successful landing in high-altitude flight test

FAN Editor

Starship prototype SN10 returns for a soft landing on a concrete pad at the company’s facility in Boca Chica, Texas.

SpaceX

SpaceX’s Starship prototype exploded shortly after landing for the first time following a high-altitude flight test on Wednesday.

The cause of the explosion, or whether it was intentional, was not immediately clear. Elon Musk alternatively refers to explosions as “RUDs,” or Rapid Unscheduled Disassembly.

The company test flew Starship rocket Serial Number 10, or SN10. SpaceX aimed to launch the prototype as high as 10 kilometers, or about 32,800 feet altitude. There were no passengers onboard the rocket, as it is a development vehicle and flies autonomously.

The SN10 flight was similar to the ones SpaceX conducted in December and February, when it test flew prototypes SN8 and SN9, respectively. Both prior rockets completed several development objectives – including testing aerodynamics, shutting down the engines in succession, and flipping to orient for landing –but both prototypes exploded on impact as they attempted to land, unable to slow down enough.

Like SN8 and SN9, the goal of the SN10 flight was not necessarily to reach the maximum altitude, but rather to test several key parts of the Starship system. SpaceX fired all three engines for liftoff and then shut them down one at a time in sequence as the rocket neared the top of the flight’s intended altitude.

SN10 then transferred propellant from the main tanks to the header tanks, before flipping itself for the “belly flop” reentry maneuver – which gives it a controlled descent through the air with the rocket’s four flaps. Then, in the final moments of descent, SpaceX flipped the rocket and returned it to a vertical orientation, firing the Raptor engines to slow itself down for the landing.

Starship SN10 lights its three engines and flips before landing.

SpaceX

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.

Free America Network Articles

Leave a Reply

Next Post

Emergent BioSolutions says it can make 1 billion Covid vaccine doses annually

As the U.S. makes headway in its coronavirus vaccination campaign, Emergent BioSolutions CEO Bob Kramer appeared on CNBC Wednesday to explain his company’s role in manufacturing doses. The Gaithersburg, Maryland-based contractor last year landed a multi-year deal to be the domestic producer of the Covid-19 vaccine from Johnson & Johnson, […]

You May Like